2D Echocardiography with Colour Doppler

Echocardiography is the umbrella term for any cardiac imaging technique that uses ultrasound — high-frequency sound waves — to visualise the heart. A transthoracic echocardiogram (TTE) is the standard, most common form of echocardiography, performed by placing a probe on the chest wall from outside the body. 2D Echocardiography with Colour Doppler is built on this TTE platform, combining real-time two-dimensional imaging with Colour Doppler flow mapping in a single study. This page covers the standard TTE with Colour Doppler. Two related but distinct tests exist for specific situations: the transoesophageal echocardiogram (TOE), which uses a probe passed via the oesophagus for higher-resolution images of specific structures, and the stress echocardiogram, which compares wall motion at rest and under exercise or pharmacological stress to detect coronary artery disease. Each requires its own preparation and serves a different clinical question. Before interpreting what the test detects, it helps to have a working knowledge of cardiac anatomy — the structures the test images. The heart has four chambers — the right and left atria (the receiving chambers) and the right and left ventricles (the pumping chambers) — separated by four valves: the mitral and tricuspid valves, which sit between the atria and ventricles, and the aortic and pulmonary valves, which guard the exits to the body and lungs. The entire heart sits within a thin fibrous sac called the pericardium. A complete 2D Echocardiography with Colour Doppler study images all four chambers, all four valves, the great vessels at their origins, and the pericardial sac — a comprehensive structural survey of the heart in a single session.

Colour Doppler works on the principle of Doppler ultrasound: sound waves reflected from moving red blood cells return to the probe at a slightly different frequency than they were sent — a phenomenon called the Doppler shift. The direction and magnitude of this frequency shift encode both the speed and the direction of blood flow. The echocardiography machine translates this shift in real time into a colour-coded map overlaid on the 2D image — conventionally, red indicates flow moving toward the probe, and blue indicates flow moving away. Colour Doppler is systematically applied across all four cardiac valves, with the mitral and aortic valves receiving particular clinical scrutiny because disease at these two valves is both more common and more consequential. Turbulent, high-velocity, or reversed flow signals at a valve indicate stenosis (narrowing) or regurgitation (leakage) — abnormalities that would be completely invisible on 2D imaging alone. This is what makes Colour Doppler indispensable for diagnosing and grading valvular heart disease.

The test's primary task is to assess left ventricular function — both how forcefully the left ventricle contracts (systolic function) and how well it relaxes and fills between beats (diastolic function). Ejection fraction (EF) is the number that captures the systolic half of this assessment in a single reproducible figure: it expresses, as a percentage, how much blood the left ventricle ejects with each beat. It is this figure — above or below specific guideline thresholds — that determines whether a patient's heart failure is classified as reduced, mildly reduced, or preserved ejection fraction. Colour Doppler complements this by measuring blood flow velocity and direction through each valve, detecting leakage (regurgitation) and narrowing (stenosis) with quantitative precision.

Left ventricular function encompasses more than how forcefully the heart contracts. When the ventricle stiffens and fails to relax normally between beats — a pattern called diastolic dysfunction — ejection fraction may remain completely normal, yet the patient still develops heart failure with preserved ejection fraction (HFpEF). This is one of the most important, and most commonly missed, diagnoses in cardiology — because a normal EF is often, incorrectly, taken to mean a normal heart. 2D Echocardiography with Colour Doppler detects diastolic dysfunction through specific Doppler flow patterns measured across the mitral valve — principally the E/A ratio (the relative speed of early versus late ventricular filling) and the E/e' ratio (a Tissue Doppler-derived estimate of left atrial filling pressure). An elevated E/e' ratio is the key echo signature that allows your cardiologist to identify HFpEF and distinguish it from HFrEF — a distinction that materially changes the treatment plan.

Beyond the global EF figure, 2D imaging assesses each of the standard left ventricular wall segments individually. When 2D imaging reveals a regional wall motion abnormality — a segment of the left ventricular wall that hypokineses (moves weakly), akineses (does not move), or moves paradoxically — the finding is the echocardiographic hallmark of myocardial ischaemia or prior infarction in that territory. Because each LV segment corresponds to a specific coronary artery, the distribution of wall motion abnormalities can help localise the culprit vessel — for example, abnormal motion confined to the anterior wall and septum points toward the left anterior descending (LAD) artery. This relationship is what makes 2D Echocardiography a valuable first-line tool in the workup of chest pain and suspected coronary artery disease.

2D Echocardiography with Colour Doppler can also visualise pericardial disease — conditions affecting the thin fibrous sac surrounding the heart. A pericardial effusion (fluid build-up) appears as a dark, echo-free space surrounding the heart on 2D imaging. In more severe cases, where fluid accumulates rapidly or in large volume, the 2D images can show diastolic collapse of the right ventricle — the hallmark of cardiac tamponade, a haemodynamically critical, time-sensitive finding that demands urgent management. Untreated, severe valvular heart disease — particularly aortic stenosis and mitral regurgitation — is itself a cause of heart failure, as the heart muscle progressively fails under the abnormal pressure or volume load the diseased valve imposes. This is why Colour Doppler grading of valve severity is not just a diagnostic label but a direct driver of the treatment timeline.